awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38653663-483CDE3C-8DF6-4DD4-8341-65C105D70A50
Q38653663-483CDE3C-8DF6-4DD4-8341-65C105D70A50
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38653663-483CDE3C-8DF6-4DD4-8341-65C105D70A50
Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches.
P2860
Q38653663-483CDE3C-8DF6-4DD4-8341-65C105D70A50
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38653663-483CDE3C-8DF6-4DD4-8341-65C105D70A50
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6ac2a4ef029bc043dd209a0d1e6ae639fe726ed2
P2860
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.